{
    "clinical_study": {
        "@rank": "45187", 
        "arm_group": {
            "arm_group_label": "DEB025", 
            "arm_group_type": "Experimental", 
            "description": "DRUG"
        }, 
        "brief_summary": {
            "textblock": "This is an open-label study to evaluate the pharmacokinetics, safety and tolerability of\n      single oral doses of DEB025 in subjects with mild and moderate hepatic impairment compared\n      to matched healthy subjects with normal liver function."
        }, 
        "brief_title": "Evaluate the Pharmacokinetics, Safety, and Tolerability of DEB025 in Subjects With Hepatic Impairment Compared to Healthy Subjects", 
        "condition": "Mild and Moderate Hepatic Impairment", 
        "condition_browse": {
            "mesh_term": "Liver Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Male or female, 18 to 70 years of age, in good health\n\n          -  Stable Child-Turcotte-Pugh score of at least 5\n\n          -  Body weight of at least 50 kg and a BMI of 18.0 to 36.0 kg/m2\n\n        Exclusion criteria:\n\n          -  Use of other investigational drugs\n\n          -  Women of child-bearing potential\n\n        Other protocol-defined inclusion/exclusion criteria may apply"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "17 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860326", 
            "org_study_id": "CDEB025A2114"
        }, 
        "intervention": {
            "arm_group_label": "DEB025", 
            "description": "DEB025 single oral dose", 
            "intervention_name": "DEB025", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "hepatic impairment", 
            "DEB025A"
        ], 
        "lastchanged_date": "September 19, 2013", 
        "number_of_arms": "1", 
        "official_title": "An Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Single Oral Doses of DEB025 in Subjects With Mild and Moderate Hepatic Impairment Compared to Matched Healthy Subjects With Normal Liver Function", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Pharmacokinetic assessment of DEB025", 
            "safety_issue": "No", 
            "time_frame": "0-168 hrs after treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860326"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Vital signs, electrocardiograms, labs, and adverse events.", 
            "measure": "Safety and tolerability of DEB025", 
            "safety_issue": "Yes", 
            "time_frame": "8 days"
        }, 
        "source": "Novartis", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}